An Extension Trial for Patients With Open-Angle Glaucoma Who Participated in the DF6-CL-20-01 Protocol.

An Extension Trial to Evaluate the Long Term Safety and Effectiveness of the STREAMLINE® SURGICAL SYSTEM in Patients With Open-Angle Glaucoma Who Participated in the DF6-CL-20-01 Protocol.

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06230393

Enrollment

Registered

2024-01-30

Start date

2024-06-01

Completion date

2025-12-04

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraocular Pressure, Open Angle Glaucoma

Keywords

Intraocular Pressure, Glaucoma, MIGS

Brief summary

The purpose of this study is to evaluate long term safety and effectiveness of the STREAMLINE® SURGICAL SYSTEM

Detailed description

A Retrospective, nonrandomized, open-label study to evaluate the long term safety and IOP-lowering effectiveness of STREAMLINE® SURGICAL SYSTEM in patients with open-angle glaucoma who participated in the DF6-CL-20-01 protocol.

Interventions

DEVICESTREAMLINE® SURGICAL SYSTEM

STREAMLINE® SURGICAL SYSTEM

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Inclusion criteria

participated in the DF6-CL-20-01 trial.

Exclusion criteria

lost to follow up in the DF6-CL-20-01 trial

Design outcomes

Primary

Measure	Time frame	Description
Change in IOP	24months; 36 months; 48months, 60 months	From Screening to annual endpoints

Secondary

Measure	Time frame	Description
Number of IOP lowering medications	24months; 36 months; 48months, 60 months	Compared to screening in DF6-CL-20-01 trial

Countries

Costa Rica

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026